Hereditary Prostate Cancer Panel Test code: 01362 • 10–21 days turnaround time Up to 16 genes

Hereditary Prostate Cancer Panel                            Up to 16 genes

This panel analyzes genes associated with an adult-onset hereditary predisposition to prostate cancer. It is designed to evaluate multiple genetic factors that may contribute to an individual's increased risk of developing prostate cancer.

Hereditary prostate cancer conditions can have significant genetic heterogeneity and overlapping clinical features, making it difficult to identify the underlying genetic cause based solely on personal history, family history, or clinical presentation. Broad panel testing allows for an efficient evaluation of multiple potential genes based on a single clinical indication.

Genetic testing may provide valuable information by helping to:

• Confirm or clarify a clinical diagnosis

• Identify an inherited predisposition to prostate cancer

• Assess hereditary cancer risk

• Guide appropriate cancer screening and surveillance

• Support earlier detection and intervention

• Help inform disease prognosis and progression

• Inform family planning and genetic counseling

• Identify potentially affected relatives who may benefit from genetic testing

• Support consideration for relevant clinical trials

Some genes included in this panel may also be associated with additional medical conditions unrelated to hereditary prostate cancer. These conditions are not included among the disorders specifically evaluated by this test.

Important Testing Information:
This panel is specifically designed to identify heritable germline genetic variants. It is not intended to detect somatic mutations in tumor tissue and should not be used as a substitute for tumor-based somatic testing.